Budke, Brian <br/><br/>
An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity.  [electronic resource] 

 -  Journal of medicinal chemistry  Jan 2013 
 - 254-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1520-4804 
<br/><br/><label>Standard No.: </label>10.1021/jm301565b  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Binding Sites<br/>DNA--chemistry<br/>DNA Repair--drug effects<br/>HEK293 Cells<br/>Homologous Recombination--drug effects<br/>Humans<br/>Maleimides--chemical synthesis<br/>Morpholines--chemical synthesis<br/>Protein Binding<br/>Pyrroles--chemistry<br/>Rad51 Recombinase--antagonists & inhibitors<br/>Structure-Activity Relationship